HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

Based on an Avalere Health report, Community Oncology Alliance warns that IRA negotiations could slice down payments needed ...

PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.

Jim Furniss and Chris Teale discuss the market access environment for new oncology products in Europe, including sales comparisons with the US and their thoughts on the future. What do we mean by ...

Vadodara: Alembic Pharma has announced that Sudhakar Pandiyan has been appointed as Head - Technical Operations (Sterile & ...

US FDA issues draft guidance on conducting multiregional clinical trials in oncology: Maryland Wednesday, September 18, 2024, 14:00 Hrs [IST] The US Food and Drug Administration i ...

L.C. proudly announces the appointment of Dr. Rico Buchli as Chief Scientist. In his new role, Dr. Buchli will ...

Research highlights the use of multimodal machine learning to identify non-small cell lung cancer patients predicted to ...

The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...